ARTICLE | Clinical News
Argenta reports Phase II COPD data
September 16, 2009 1:05 AM UTC
In a Phase II trial in 91 patients with chronic obstructive pulmonary disease (COPD), Argenta Discovery Ltd. (Harlow, U.K.) said its ADC4022 plus inhaled budesonide significantly improved lung functio...